Stephen Pettitt

30PUBLICATIONS
226CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Sep 22, 2026
The anion channel GPR89 is a tumor-specific dependency in breast cancer.

|Sep 21, 2026
PUM3 is an essential suppressor of replication stress in homologous recombination deficient breast cancer.

|Jul 15, 2026
LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor Combinations.

|Jul 29, 2025
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers.

Roman M Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki

|Jul 08, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models.

Joan Kyula-Currie, Victoria Roulstone, James Wright

|Mar 03, 2025
The transcriptomic architecture of common cancers reflects synthetic lethal interactions.

Syed Haider, Rachel Brough, Santiago Madera

Pageof 5

Frequent Collaborators

22 joint publications

Christopher J Lord

11 joint publications

Andrew Tutt

9 joint publications

Syed Haider

9 joint publications

Dragomir Krastev